- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.07. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 29.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 28.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 18.06. | VITA LIFE SCIENCES LIMITED: Cleasing Statement | - | ASX | ||
| 18.06. | VITA LIFE SCIENCES LIMITED: Application for quotation of securities - VLS | - | ASX | ||
| 12.06. | VITA LIFE SCIENCES LIMITED: Guidance | - | ASX | ||
| 11.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 09.06. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 09.06. | VITA LIFE SCIENCES LIMITED: Notification regarding unquoted securities - VLS | - | ASX | ||
| 09.06. | VITA LIFE SCIENCES LIMITED: Notification regarding unquoted securities - VLS | - | ASX | ||
| 05.06. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 01.06. | VITA LIFE SCIENCES LIMITED: On Market Share Buy Back | - | ASX | ||
| 01.06. | VITA LIFE SCIENCES LIMITED: Notification of buy-back - VLS | - | ASX | ||
| 29.05. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 28.05. | VITA LIFE SCIENCES LIMITED: Results of Meeting | - | ASX | ||
| 28.05. | VITA LIFE SCIENCES LIMITED: AGM Address and Presentation | - | ASX | ||
| 21.05. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 21.05. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 19.05. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 18.05. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GREEN THUMB INDUSTRIES | 6,350 | +2,92 % | Drama um Canopy, Tilray & Co?: Anhörungsprozess zu Cannabis endet - Stürzt die DEA den Sektor ins Chaos? | © Foto: adobe.stock.comAm 29. Juni begann der Anhörungsprozess der DEA zur möglichen Neueinstufung von Freizeit-Cannabis in Schedule III. Mittlerweile steht der Anhörungsprozess vor seinem Ende. Was... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 61,86 | -0,58 % | Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis | Two global registrational Phase 3 trials initiated in ZENITH AD program
Phase 3 program based upon clinically meaningful efficacy and favorable safety data observed... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 238,30 | +1,02 % | ALNYLAM PHARMACEUTICALS INC: Struktur im Stillstand | ||
| FILANA THERAPEUTICS | 0,797 | +1,53 % | Filana Therapeutics, Inc.: Filana Therapeutics Reports Q1 2026 Financial Results and Business Update | AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for... ► Artikel lesen | |
| ADASTRA | 0,115 | 0,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 9,920 | -0,40 % | DesignRush: Brooke Sellas Joins DesignRush Podcast on Social Media's Revenue Risk | Miami, Florida--(Newsfile Corp. - June 23, 2026) - The latest episode of the DesignRush Podcast features Brooke Sellas, founder and CEO of B Squared Media. The episode explores why companies risk... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 22,000 | +0,69 % | Wall Street Analysts Believe Acadia (ACAD) Could Rally 30.89%: Here's is How to Trade | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | CATALYST PHARMACEUTICALS, INC. - 15-12G, Securities registration termination | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| OPUS GENETICS | 2,480 | -8,82 % | Opus Genetics, Inc.: Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results | RESEARCH TRIANGLE PARK, N.C., July 09, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the "Company", "Opus Genetics" or "Opus"), a clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 68,00 | +1,49 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET | ||
| SOLIGENIX | 0,377 | +2,59 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and First Quarter 2026 Financial Results | PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,300 | 0,00 % | XFRA G1G: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZELIRA THERAPEUTICS... ► Artikel lesen | |
| SAVARA | 4,885 | +0,89 % | Here's Why You Should Add Savara Stock to Your Portfolio Now | ||
| BIODEXA PHARMACEUTICALS | 1,650 | 0,00 % | Biodexa Pharmaceuticals PLC: Result of Annual General Meeting | June 30, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Result of Annual General Meeting Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) ("Biodexa" or "the Company"), a clinical stage biopharmaceutical... ► Artikel lesen |
VITA LIFE SCIENCES LIMITED gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.